Adaptive Biotech, Takeda collaborate to measure disease with clonoSEQ® assay.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sy...

April 14, 2023 | Friday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
ZyVersa Publishes Review Article on Targeting Microglial Inflammation in Alzheimer's Disease

During aging, the central nervous system (“CNS”) becomes more inflammatory, leading to activation of microglia (“CNS immune cells&rdquo...

April 13, 2023 | Thursday | News
From tragedy, a potential pediatric cancer treatment

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides (ASOs)—m...

April 13, 2023 | Thursday | News
Sana Biotech's Hypoimmune Pancreatic Cells Control Type 1 Diabetes in Preclinical Model

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the im...

April 13, 2023 | Thursday | News
RxToolKit and NeuroNet Pro Announce Partnership to Improve Clinical Education and Safety for Neurology Practices

This collaboration extends preferred pricing on RxToolKit's software solutions in addition to other exclusive benefits already available to NeuroNet Pro me...

April 12, 2023 | Wednesday | News
Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer

The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-le...

April 12, 2023 | Wednesday | News
COVID -19 Recommendations Map offers accessible pandemic guidelines

The RecMap is available here = https://covid19.recmap.org The RecMap is a one-stop shop for clinical, public health and health policy COVID-19 recommendat...

April 12, 2023 | Wednesday | News
ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310

“This submission is an important milestone for the ProMIS team as we advance our lead compound, PMN310, toward the clinic. We are excited to continue...

April 11, 2023 | Tuesday | News
GC Genome shows Liquid Biopsy Technology can predict response to Radiation Therapy in Solid Tumors

The research was in collaboration with the Samsung Medical Center, Sungkyunkwan University School of Medicine. This study adds to the previous studies of p...

April 10, 2023 | Monday | News
First Avenue Ventures Fund I invests in Diamond Therapeutics for Mental Health Innovation

Proceeds from the fund's investment will support Diamond's collaboration with UAB on an investigator-led clinical trial of low-dose psilocybin to treat dem...

April 10, 2023 | Monday | News
Why Compliance Matters and Why Patients Should Care

Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...

April 09, 2023 | Sunday | Opinion
Supreme Court of Canada upholds BC Supreme Court's landmark decision protecting public health care

BCs’ Act at the centre of this case aims to preserve a publicly-funded health care system where access to necessary medical care is based on patients...

April 09, 2023 | Sunday | Regulatory
Covis Statement on FDA Decision to Withdraw Approval of Makena®

The decision from the FDA Commissioner and Chief Scientist deferred to the Center for Drug Evaluation and Research (CDER) to determine next steps to implem...

April 09, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close